Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Archives of Gynecology and Obstetrics|February 26, 2013
Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type IICheguo Tsai, Juliana S Leslie, Laura G Franko-Tobin, et al.
Molecular and Cellular Biochemistry|December 19, 2002
A selective somatostatin type-2 receptor agonist inhibits neointimal thickening and enhances endothelial cell growth and morphology following aortic balloon injury in the rabbitNatalie K Schiller, Alvin M Timothy, Harmeet S Aurora, et al.
The Oncologist|February 1, 2012
Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeuticsLaura G Franko-Tobin, L Vienna Mackey, Wei Huang, et al.
Chinese Medical Journal|February 21, 2012
Comparisons of multiple characteristics between young and old lung cancer patientsWei Jiang, Yue Kang, Guang-Yue Shi, et al.
Biochemical and Biophysical Research Communications|January 14, 2024
Biological evaluation of 9-thioansamitocin P3Natalya I Vasilevich, Huangyu Jiang, Haihua Xiao, et al.
Biochemical and Biophysical Research Communications|November 22, 2005
Downregulation of MDM2 expression by RNAi inhibits LoVo human colorectal adenocarcinoma cells growth and the treatment of LoVo cells with mdm2siRNA3 enhances the sensitivity to cisplatinYan Yu, Ping Sun, Li-chun Sun, et al.
Pageof 8